Avid Bioservices Inc (CDMO)

[cjgaddy]

June2015: Dr.Raymond.Birge & Dr.Xianming.Huang (Dr.Rolf.Brekken-Lab) at Gordon Res. Conference in Maine – speaking next to each other in “Consequences of Lipid Alterations” Session on 6-15-15. Peregrine was the only corp. contributor to this conference, specified as, “In Memory of Dr. Philip E. Thorpe.”...

June 14-19, 2015: “Apoptotic Cell Recognition & Clearance”, Gordon Research Conference, Biddeford, ME
Chair: David S. Ucker, Vice Chairs: Peter Henson & Kirsten Lauber
http://www.grc.org/programs.aspx?id=13127
”Moreover, apoptotic cells are potently immunosuppressive, and their clearance occurs in the absence of inflammation. Recognition & inflammatory modulation represent key elements of an innate immunity that discriminates live from effete cells.”
**The only Corp. Sponsor: PEREGRINE PHARM, “Generous financial support from Peregrine Pharmaceuticals is in memory of Dr. Philip E. Thorpe.”
- - - - - - - -
SESSION: “Consequences of Lipid Alterations for Apoptotic Cell Clearance
Discussion Leader: Christopher Gregory (Univ. of Edinburgh, UK)
7:30pm: Ian Dransfield (Univ. of Edinburgh, UK), “Protein S Binding to Apoptotic Cells...”
8:10pm: Dr. Raymond Birge (Rutgers NJMS), “Apoptotic Cell Recognition Receptors, Tyro3/Axl/Mer...”
8:50pm: Dr. Xianming Huang** (UTSW-MC/Dallas, Brekken Lab), “PS-Targeting Antibodies Overcome Tumor Immunosuppression and Synergize with Immune Checkpoint Blockade"
**Dr. Xianming Huang: formerly in Dr. Philip Thorpe's Lab (RIP, Dr. Thorpe, 1951-2013 http://tinyurl.com/l9gqmt5 ), now in Dr. Rolf Brekken's (PPHM SAB) Lab.
http://www.utsouthwestern.edu/labs/brekken/

= = = = = = = = = = = = = =
...Dr. Raymond Birge has authored ~85 scientific publications in molecular & cancer biology. http://www.ncbi.nlm.nih.gov/pubmed/?term=birge+rb
“The Birge laboratory conducts basic science focused on the eradication of cancer.”
http://birgelab.org => http://birgelab.org/biography.html

Dr. Raymond Birge spoke at Peregrine's 11-2015 “Sci. Session” at SITC'15/Maryland ( http://tinyurl.com/pbof95w ); will be the chair in June 2016 of the ICDS'16/Ireland session where Dr. Rolf Brekken (PPHM SAB) is speaking on “Blockade of PS & Immune Activation in Cancer”; and now also speaking in late June'16 at ICHC'16/Istanbul on, “Phosphatidylserine is a Global Immunosuppressive Signal in Cell Death & Cancer”.

3-1-14/Youtube: “Cancer Research” - Dr. Raymond Birge Laboratory, Rutgers http://birgelab.org

Dr. Ray Birge/2:54: "The immune system is very complex and if it can recognize tumors as being foreign to the body, then it can reactivate & eliminate these tumors to treat as a chronic disease, or in some cases eliminate the tumors. One of the projects that our lab is interested in is how to reactivate the immune system toward particular cancers, and we believe that the type of cell death that cancer cells undergo will determine whether or not they'll be an immune reaction against the cancer. If cells die, through a process called apoptosis, in a certain way, they can reactivate / activate the immune system and give a durable, anti-tumor response. The problem that we're trying to understand is how the tumor cells evade the immune system and therefore block these immune-suppressing signals to reactivate the immune system against cancer..."

MORE:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=120059503
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=120060958